Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report
Wilgucki, Molly, Yeung, Vincent, Ho, Grace, Bravo Montenegro, Gabriela L., Jones, Greg, Reuss, Joshua E., Liu, Stephen V., Kim, Chul
Published in JTO clinical and research reports (01.10.2022)
Published in JTO clinical and research reports (01.10.2022)
Get full text
Journal Article
Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report
Wilgucki, Molly, Yeung, Vincent, Ho, Grace, Bravo Montenegro, Gabriela L, Jones, Greg, Reuss, Joshua E, Liu, Stephen V, Kim, Chul
Published in JTO clinical and research reports (01.10.2022)
Published in JTO clinical and research reports (01.10.2022)
Get full text
Report